Align Technology, Inc. (NASDAQ:ALGN – Free Report) – Equities researchers at William Blair raised their Q2 2025 earnings per share (EPS) estimates for Align Technology in a research note issued to investors on Thursday, July 25th. William Blair analyst B. Vazquez now forecasts that the medical equipment provider will earn $2.28 per share for the quarter, up from their previous forecast of $2.20. The consensus estimate for Align Technology’s current full-year earnings is $7.84 per share.
Align Technology (NASDAQ:ALGN – Get Free Report) last posted its earnings results on Wednesday, July 24th. The medical equipment provider reported $2.41 EPS for the quarter, beating the consensus estimate of $2.32 by $0.09. Align Technology had a return on equity of 14.07% and a net margin of 11.34%. The firm had revenue of $1.03 billion for the quarter, compared to analyst estimates of $1.04 billion. During the same quarter in the prior year, the company posted $1.73 earnings per share. Align Technology’s revenue for the quarter was up 2.6% compared to the same quarter last year.
Several other research firms also recently issued reports on ALGN. Piper Sandler decreased their price objective on shares of Align Technology from $330.00 to $315.00 and set an “overweight” rating for the company in a research note on Thursday. Stifel Nicolaus decreased their price objective on shares of Align Technology from $400.00 to $350.00 and set a “buy” rating for the company in a research note on Thursday. StockNews.com downgraded shares of Align Technology from a “buy” rating to a “hold” rating in a research note on Thursday. Evercore ISI decreased their target price on shares of Align Technology from $370.00 to $300.00 and set an “outperform” rating for the company in a research note on Monday, June 10th. Finally, Morgan Stanley decreased their target price on shares of Align Technology from $328.00 to $310.00 and set an “overweight” rating for the company in a research note on Thursday. One analyst has rated the stock with a sell rating, four have assigned a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Align Technology currently has an average rating of “Hold” and a consensus target price of $322.78.
View Our Latest Stock Analysis on Align Technology
Align Technology Price Performance
NASDAQ ALGN opened at $220.45 on Monday. Align Technology has a 1 year low of $176.34 and a 1 year high of $413.20. The company has a market capitalization of $16.60 billion, a PE ratio of 36.32, a P/E/G ratio of 4.09 and a beta of 1.66. The company has a fifty day moving average of $249.03 and a two-hundred day moving average of $280.62.
Institutional Investors Weigh In On Align Technology
A number of hedge funds have recently added to or reduced their stakes in the company. Norges Bank purchased a new position in Align Technology in the fourth quarter valued at about $223,610,000. Brown Advisory Inc. increased its holdings in Align Technology by 41.4% in the fourth quarter. Brown Advisory Inc. now owns 1,509,080 shares of the medical equipment provider’s stock valued at $413,488,000 after buying an additional 441,754 shares in the last quarter. Swedbank AB purchased a new position in Align Technology in the first quarter valued at about $96,117,000. Bares Capital Management Inc. increased its holdings in Align Technology by 44.4% in the first quarter. Bares Capital Management Inc. now owns 819,930 shares of the medical equipment provider’s stock valued at $268,871,000 after buying an additional 252,220 shares in the last quarter. Finally, Envestnet Asset Management Inc. increased its holdings in Align Technology by 102.0% in the fourth quarter. Envestnet Asset Management Inc. now owns 414,772 shares of the medical equipment provider’s stock valued at $113,648,000 after buying an additional 209,419 shares in the last quarter. Institutional investors and hedge funds own 88.43% of the company’s stock.
About Align Technology
Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company’s Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.
See Also
Receive News & Ratings for Align Technology Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Align Technology and related companies with MarketBeat.com’s FREE daily email newsletter.
